CytomX Therapeutics, Inc.

• CytomX Therapeutics, Inc. Estimates – NASDAQ:CTMX
  TradingView · 23 Oct 2026
• Cantor Fitzgerald reiterates USD 12 target for CytomX Therapeutics stock
  AD HOC NEWS · 20 Oct 2026
• CytomX Therapeutics stock closed at USD 2.28, down 5.39 percent on October 16
  AD HOC NEWS · 17 Oct 2026
• Form 4 CytomX Therapeutics Inc: Sean A. McCarthy (Director, CEO) For: 6 November
  Investing.com India · 17 Oct 2026
• CytomX CEO Sean McCarthy sells $461,906 in stock
  Investing.com · 17 Oct 2026
• CEO exercised options and sold 101,793 CytomX Therapeutics (CTMX) shares under a trading plan.
  Stock Titan · 16 Oct 2026
• CytomX Therapeutics stock trades ahead of November 5 results
  AD HOC NEWS · 15 Oct 2026
• CytomX Therapeutics (NasdaqGS:CTMX) Stock Forecast & Analyst Predictions
  Simply Wall Street · 13 Oct 2026
• Cantor Fitzgerald reiterates Overweight on CytomX stock, $12 target
  Investing.com · 13 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →